retinitis

Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

---

Study Counts

Type	Study_count
Total_Studies	189
interventional	145
Observational	39
Registry	5

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type	Study_Count
Drug	70
Device	26
Biological	15
Other	5
Procedure	5
Drug|placebo	4
Drug|Other	3
Behavioral	2
Biological|Other	2
Dietary Supplement|placebo	2
Genetic	2
Behavioral|Other	1
Biological|Combination Product	1
Combination Product	1
Device|Drug	1
Device|Procedure	1
Diagnostic Test|Drug|Other	1
Dietary Supplement|Drug	1
Dietary Supplement|Other	1
Drug|Procedure	1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country	Study_Count
United States	75
NA	10
France	7
United States|Canada	5
Israel	3
Italy	3
Turkey	3
United States|United Kingdom	3
Australia	2
Brazil	2
China	2
Germany	2
Hong Kong	2
Spain	2
United Kingdom	2
United States|Canada|Germany|Netherlands|United Kingdom	2
Austria	1
Austria|France|Germany	1
Austria|France|Germany|Spain|United Kingdom	1
Belgium|Italy	1
Canada|Ireland	1
Denmark|Germany|Norway	1
Germany|Hungary|United Kingdom	1
India	1
Indonesia	1
Jordan	1
Korea, Republic of	1
Lebanon	1
Mexico	1
Poland	1
Sweden	1
Thailand	1
United States|Belgium|Canada|France	1
United States|France|Germany|Portugal	1
United States|France|United Kingdom	1
United States|United Arab Emirates	1

Sites per Study

Site_count	Study_Count
1	78
2	14
3	5
4	3
5	6
6	7
7	4
8	3
9	6
11	2
12	2
13	3
14	1
17	2
18	1
19	2
20	2
22	1
23	1
25	1
36	1

Phase

Phase	Study_Count
N/A	60
Phase 2	23
Phase 1	22
Phase 1/Phase 2	19
Phase 3	12
Phase 2/Phase 3	4
Phase 4	4
Early Phase 1	1

Number of Arms

Number_of_Arms	Count_of_Studies
1	38
2	31
3	13
4	2
5	2
6	1
7	1
9	1
12	1
NA	55

Enrollment Metrics by Phase

Measure	Early.Phase.1	N.A	Phase.1	Phase.1.Phase.2	Phase.2	Phase.2.Phase.3	Phase.3	Phase.4
Min.	50	2.0000	5.0	7.00000	10.0000	63.00	32.00	1.00
1st Qu.	50	18.7500	10.0	15.75000	48.0000	63.75	90.75	30.25
Median	50	46.5000	22.0	20.50000	78.0000	82.00	207.00	76.00
Mean	50	133.0192	22.6	24.22222	139.7619	109.00	171.00	113.25
3rd Qu.	50	101.2500	30.0	29.50000	167.0000	127.25	238.50	159.00
Max.	50	1200.0000	53.0	50.00000	850.0000	209.00	279.00	300.00

Trial Group Type

group_type	Group_Count
Experimental	123
NA	55
Active Comparator	35
Placebo Comparator	12
Sham Comparator	9
Other	7
No Intervention	5

Intervention Model

intervention_model	Study_Count
Single Group Assignment	46
NA	41
Parallel Assignment	40
Sequential Assignment	11
Crossover Assignment	4
Factorial Assignment	3

Primary Purpose

primary_purpose	Study_Count
Treatment	123
Other	10
Basic Science	2
Device Feasibility	2
Diagnostic	2
Prevention	2
NA	2
Health Services Research	1
Screening	1

Observational Studies

Studies by Country

Country	Study_Count
United States	21
United Kingdom	3
France	2
Israel	2
Japan	2
Germany	1
NA	1
Russian Federation	1
Taiwan	1
United States|Belgium|Brazil|Canada|France|Germany|Israel|Netherlands|Poland|United Kingdom	1
United States|Canada|Denmark|Germany|Netherlands|Switzerland|United Kingdom	1
United States|Canada|France|Germany|Netherlands|United Kingdom	1
United States|Canada|Israel|Singapore|United Kingdom	1
United States|China|India|Pakistan	1

Sites per Study

Site_count	Study_Count
1	23
2	4
3	1
4	1
5	1
6	1
9	1
16	2
17	1
19	1
25	1
26	1
52	1

Enrollment Metrics

Measure	Observational
Min	1.0000
1st Qu	46.2500
Median	82.5000
Mean	662.3158
3rd Qu	236.7500
Max	6618.0000

Observation Model

observational_model	Study_Count
Cohort	15
NA	8
Case-Control	6
Case-Only	3
Case Control	2
Case-Crossover	1
Defined Population, Natural History	1
Ecologic or Community	1
Family-Based	1
Other	1

Time Perspective

time_perspective	Study_Count
Prospective	23
NA	7
Retrospective	5
Cross-Sectional	3
Other	1

Registries

Studies by Country

Country	Study_Count
France	1
Mexico	1
Russian Federation	1
United States	1
United States|Australia	1

Sites per Study

Site_count	Study_Count
1	2
2	1
3	1
6	1

Enrollment Metrics

Measure	Registries
Min	28.0
1st Qu	1000.0
Median	17000.0
Mean	11605.6
3rd Qu	20000.0
Max	20000.0

Registry Model

observational_model	Study_Count
Cohort	2
Case-Only	1
Family-Based	1
Other	1

Time Perspective

time_perspective	Study_Count
Prospective	5

Follow-up

target_duration	Study_Count
100 Years	1
20 Years	1
3 Years	1
5 Years	1
8 Months	1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id	brief_title	link	overall_status	source	primary_completion_date
NCT03381235	Exercise and RP (AVAMC and Emory)	https://ClinicalTrials.gov/show/NCT03381235	Completed	Emory University	2018-11-28
NCT03374657	A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT03374657	Recruiting	Novartis	2026-07-28
NCT03368027	Effectiveness of a Cognitive-behavioral Program of Coping With Psychological Stress in People With Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT03368027	Completed	Universidad de Granada	2018-12-03
NCT03328130	Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B Gene	https://ClinicalTrials.gov/show/NCT03328130	Recruiting	Horama S.A.	2022-09-30
NCT03316560	Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations	https://ClinicalTrials.gov/show/NCT03316560	Recruiting	Applied Genetic Technologies Corp	2023-03-31
NCT03252847	Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) Retinitis Pigmentosa GTPase Regulator (RPGR)	https://ClinicalTrials.gov/show/NCT03252847	Active, not recruiting	MeiraGTx UK II Ltd	2020-11-30
NCT03248388	Argus II/ORCAM Device Study	https://ClinicalTrials.gov/show/NCT03248388	Recruiting	Mayo Clinic	2021-12-31
NCT03116113	A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT03116113	Recruiting	NightstaRx Ltd, a Biogen Company	2021-03-31
NCT03078309	The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients	https://ClinicalTrials.gov/show/NCT03078309	Recruiting	Hadassah Medical Organization	2020-08-31
NCT03073733	Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT03073733	Active, not recruiting	jCyte, Inc	2020-09-30
NCT03063021	The FIGHT-RP1 Study	https://ClinicalTrials.gov/show/NCT03063021	Completed	Johns Hopkins University	2019-02-11
NCT03057496	Collision Warning Device for Blind and Visually Impaired	https://ClinicalTrials.gov/show/NCT03057496	Completed	Massachusetts Eye and Ear Infirmary	2019-11-08
NCT02909985	Visual Activity Evoked by Infrared in Humans After Dark Adaptation	https://ClinicalTrials.gov/show/NCT02909985	Completed	University of New Mexico	2016-08-31
NCT02837640	Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT02837640	Recruiting	Beirut Eye Specialist Hospital	2017-06-30
NCT02720640	Safety and Efficacy of the Alpha AMS Subretinal Implant	https://ClinicalTrials.gov/show/NCT02720640	Completed	University of Oxford	2017-10-31
NCT02709876	Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT02709876	Active, not recruiting	Stem Cells Arabia	2020-09-30
NCT02670980	Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy	https://ClinicalTrials.gov/show/NCT02670980	Completed	Pixium Vision SA	2019-05-31
NCT02614651	AUgmented REality for the Visually Impaired - Part 1	https://ClinicalTrials.gov/show/NCT02614651	Completed	Centre Hospitalier Universitaire de NÄ«mes	2017-04-20
NCT02609165	Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema	https://ClinicalTrials.gov/show/NCT02609165	Completed	Ospedale San Raffaele	2017-02-28
NCT03011541	Stem Cell Ophthalmology Treatment Study II	https://ClinicalTrials.gov/show/NCT03011541	Recruiting	MD Stem Cells	2022-01-31
NCT03406416	Study of a Suprachoroidal Retinal Prosthesis	https://ClinicalTrials.gov/show/NCT03406416	Active, not recruiting	Mobius Medical Pty Ltd.	2020-12-31
NCT03845218	Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome Measures	https://ClinicalTrials.gov/show/NCT03845218	Recruiting	National Institutes of Health Clinical Center (CC)	2021-03-30
NCT02556736	RST-001 Phase I/II Trial for Advanced Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT02556736	Active, not recruiting	Allergan	2020-12-03
NCT02464436	Safety and Tolerability of hRPC in Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT02464436	Recruiting	ReNeuron Limited	2020-01-31
NCT02320812	Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT02320812	Completed	jCyte, Inc	2017-07-19
NCT02280135	Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT02280135	Completed	Red de Terapia Celular	2017-03-31
NCT02244996	Cone Rescue in Retinitis Pigmentosa by the Treatment of Lycium Barbarum	https://ClinicalTrials.gov/show/NCT02244996	Completed	The Hong Kong Polytechnic University	2016-04-30
NCT02140164	Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT02140164	Completed	National Institutes of Health Clinical Center (CC)	2015-11-30
NCT02110225	A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)	https://ClinicalTrials.gov/show/NCT02110225	Completed	Dompé Farmaceutici S.p.A	2015-11-30
NCT02086890	Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT02086890	Active, not recruiting	Nova Southeastern University	2020-06-30
NCT03326336	Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT03326336	Recruiting	GenSight Biologics	2021-12-31
NCT01866397	Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration	https://ClinicalTrials.gov/show/NCT01866397	Completed	Medical University of Vienna	2002-03-31
NCT01864486	Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy	https://ClinicalTrials.gov/show/NCT01864486	Completed	Pixium Vision SA	2017-10-13
NCT01847365	TES for the Treatment of RP	https://ClinicalTrials.gov/show/NCT01847365	Completed	University of Oxford	2015-02-28
NCT01837901	Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT01837901	Completed	Okuvision GmbH	2013-08-31
NCT01835002	Transcorneal Electrical Stimulation - Multicenter Safety Study	https://ClinicalTrials.gov/show/NCT01835002	Completed	Okuvision GmbH	2014-07-31
NCT01736059	Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy	https://ClinicalTrials.gov/show/NCT01736059	Enrolling by invitation	University of California, Davis	2022-01-31
NCT01604356	Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT01604356	Completed	Johns Hopkins University	2013-12-31
NCT01603576	Pilot Study of a Suprachoroidal Retinal Prosthesis	https://ClinicalTrials.gov/show/NCT01603576	Completed	Center for Eye Research Australia	2014-08-31
NCT03963154	Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation	https://ClinicalTrials.gov/show/NCT03963154	Recruiting	Centre d’Etude des Cellules Souches	2021-12-15
NCT01560715	Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT01560715	Completed	University of Sao Paulo	2013-01-31
NCT01543906	Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)	https://ClinicalTrials.gov/show/NCT01543906	Completed	QLT Inc.	2014-07-31
NCT01531348	Feasibility and Safety of Human Bone Marrow-derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT01531348	Enrolling by invitation	Mahidol University	2020-12-31
NCT01530659	Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT01530659	Active, not recruiting	Neurotech Pharmaceuticals	2019-08-31
NCT01521793	Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)	https://ClinicalTrials.gov/show/NCT01521793	Completed	QLT Inc.	2014-05-31
NCT01497379	Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients	https://ClinicalTrials.gov/show/NCT01497379	Completed	Retina Implant AG	2014-01-31
NCT01399515	Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT01399515	Completed	Seoul National University Hospital	2013-08-31
NCT02617966	Rod and Cone Mediated Function in Retinal Disease	https://ClinicalTrials.gov/show/NCT02617966	Recruiting	National Institutes of Health Clinical Center (CC)	2024-12-30
NCT04356716	Sildenafil for Treatment of Choroidal Ischemia	https://ClinicalTrials.gov/show/NCT04356716	Recruiting	Columbia University	2021-04-30
NCT04319809	Object Finder for a Retinal Prosthesis	https://ClinicalTrials.gov/show/NCT04319809	Active, not recruiting	Minnesota HealthSolutions	2021-04-30
NCT04315025	Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT04315025	Completed	PT. Prodia Stem Cell Indonesia	2019-06-20
NCT04295304	NR600 System Retinal Prosthesis for Patients With Retinal Degenerative Diseases	https://ClinicalTrials.gov/show/NCT04295304	Recruiting	Nano Retina	2021-12-30
NCT04285398	Prospective Natural History Study of Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT04285398	Recruiting	SparingVision	2021-06-01
NCT04284293	CNS10-NPC for the Treatment of RP	https://ClinicalTrials.gov/show/NCT04284293	Recruiting	Cedars-Sinai Medical Center	2022-04-30
NCT04278131	BS01 in Patients With Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT04278131	Recruiting	Bionic Sight LLC	2022-06-30
NCT04252534	Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma	https://ClinicalTrials.gov/show/NCT04252534	Completed	Ankara Universitesi Teknokent	2019-12-30
NCT04238858	Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT04238858	Completed	Ankara Universitesi Teknokent	2017-02-28
NCT04234438	Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow Laser	https://ClinicalTrials.gov/show/NCT04234438	Completed	Ankara Universitesi Teknokent	2019-10-30
NCT04224207	Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton’s Jelly Derived Mesenchymal Stem Cells	https://ClinicalTrials.gov/show/NCT04224207	Completed	Ankara Universitesi Teknokent	2019-10-30
NCT04141891	Advancing Understanding of Transportation Options	https://ClinicalTrials.gov/show/NCT04141891	Recruiting	University of Colorado, Denver	2023-08-01
NCT04129021	Multimodal Ophthalmic Imaging	https://ClinicalTrials.gov/show/NCT04129021	Recruiting	Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts	2023-06-30
NCT04123626	A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene	https://ClinicalTrials.gov/show/NCT04123626	Recruiting	ProQR Therapeutics	2021-10-07
NCT04120883	Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)	https://ClinicalTrials.gov/show/NCT04120883	Recruiting	University of Michigan	2022-10-31
NCT04068207	Minocycline Treatment in Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT04068207	Recruiting	Sun Yat-sen University	2021-12-01
NCT04008771	Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases	https://ClinicalTrials.gov/show/NCT04008771	Completed	2C Tech Corp	2014-12-19
NCT03999021	FIGHT-RP 1 Extension Study	https://ClinicalTrials.gov/show/NCT03999021	Active, not recruiting	Johns Hopkins University	2021-06-30
NCT03780257	Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene	https://ClinicalTrials.gov/show/NCT03780257	Recruiting	ProQR Therapeutics	2021-12-31
NCT03772938	Stem Cells Therapy in Degenerative Diseases of the Retina	https://ClinicalTrials.gov/show/NCT03772938	Enrolling by invitation	Pomeranian Medical University Szczecin	2020-02-28
NCT03635645	Experimental and Clinical Studies of Retinal Stimulation	https://ClinicalTrials.gov/show/NCT03635645	Recruiting	University of Michigan	2020-10-31
NCT03444961	CAREN Argus Rehab (CARE) Study	https://ClinicalTrials.gov/show/NCT03444961	Completed	The Cleveland Clinic	2018-06-20
NCT01256697	The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT01256697	Completed	Sheba Medical Center	2009-04-30
NCT01235624	Autosomal Dominant Retinitis Pigmentosa: Prevalence of Known Genes Identification of New Loci / Genes	https://ClinicalTrials.gov/show/NCT01235624	Completed	University Hospital, Montpellier	2013-04-30
NCT01233609	Trial of Oral Valproic Acid for Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT01233609	Completed	Foundation Fighting Blindness	2015-12-31
NCT01068561	Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT01068561	Completed	University of Sao Paulo	2010-01-31
NCT01024803	Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients	https://ClinicalTrials.gov/show/NCT01024803	Completed	Retina Implant AG	2017-04-30
NCT01014052	Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations	https://ClinicalTrials.gov/show/NCT01014052	Completed	QLT Inc.	2012-08-31
NCT03944239	Safety and Efficacy of Subretinal Transplantation of Clinical Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT03944239	Recruiting	Chinese Academy of Sciences	2021-10-31
NCT04448860	Validation of Standardized Test Protocols to Assess the Impact of Visual Pathologies in Daily Life Activities	https://ClinicalTrials.gov/show/NCT04448860	Recruiting	Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts	2023-10-04
NCT00804102	Transcorneal Electrical Stimulation Therapy for Retinal Disease	https://ClinicalTrials.gov/show/NCT00804102	Completed	Okuvision GmbH	2011-04-30
NCT01680510	The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil	https://ClinicalTrials.gov/show/NCT01680510	Recruiting	Sheba Medical Center	2020-12-31
NCT00717080	The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction	https://ClinicalTrials.gov/show/NCT00717080	Completed	Aurolab	2010-05-31
NCT00661479	An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT00661479	Completed	Allergan	2009-12-31
NCT00515814	Retina Implant Pilot Trial to Evaluate Safety & Efficacy in Blind Patients Having Degenerated Photo-receptors	https://ClinicalTrials.gov/show/NCT00515814	Completed	Retina Implant AG	2009-12-31
NCT00461435	Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT00461435	Completed	Azienda Policlinico Umberto I	NA
NCT00447993	A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT00447993	Completed	Neurotech Pharmaceuticals	2009-10-31
NCT00447980	A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT00447980	Completed	Neurotech Pharmaceuticals	2010-07-31
NCT00346333	Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A	https://ClinicalTrials.gov/show/NCT00346333	Completed	National Eye Institute (NEI)	2008-12-31
NCT00345917	Safety Study in Retinal Transplantation for Retinitis Pigmentosa.	https://ClinicalTrials.gov/show/NCT00345917	Completed	Radtke, Norman D., M.D.	2012-03-31
NCT00279500	Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT00279500	Completed	Second Sight Medical Products	2014-12-31
NCT00100230	DHA and X-Linked Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT00100230	Completed	Retina Foundation of the Southwest	2012-05-31
NCT00000970	A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir	https://ClinicalTrials.gov/show/NCT00000970	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00029289	Effects of Lutein in Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT00029289	Completed	National Center for Complementary and Integrative Health (NCCIH)	NA
NCT00002437	The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS	https://ClinicalTrials.gov/show/NCT00002437	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002432	A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS	https://ClinicalTrials.gov/show/NCT00002432	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002377	A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes	https://ClinicalTrials.gov/show/NCT00002377	Completed	Hoffmann-La Roche	2002-12-31
NCT00002356	The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes	https://ClinicalTrials.gov/show/NCT00002356	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002355	A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes	https://ClinicalTrials.gov/show/NCT00002355	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002321	A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis	https://ClinicalTrials.gov/show/NCT00002321	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002299	The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS	https://ClinicalTrials.gov/show/NCT00002299	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002257	A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS	https://ClinicalTrials.gov/show/NCT00002257	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002247	A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy	https://ClinicalTrials.gov/show/NCT00002247	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002222	A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS	https://ClinicalTrials.gov/show/NCT00002222	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002187	A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis	https://ClinicalTrials.gov/show/NCT00002187	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002169	A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis	https://ClinicalTrials.gov/show/NCT00002169	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002156	A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )	https://ClinicalTrials.gov/show/NCT00002156	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002142	An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS	https://ClinicalTrials.gov/show/NCT00002142	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002135	An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access	https://ClinicalTrials.gov/show/NCT00002135	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002134	A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis	https://ClinicalTrials.gov/show/NCT00002134	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002125	A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium)	https://ClinicalTrials.gov/show/NCT00002125	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002070	Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis	https://ClinicalTrials.gov/show/NCT00002070	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002039	An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients	https://ClinicalTrials.gov/show/NCT00002039	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002034	A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS	https://ClinicalTrials.gov/show/NCT00002034	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002025	Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient	https://ClinicalTrials.gov/show/NCT00002025	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002016	A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis	https://ClinicalTrials.gov/show/NCT00002016	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002015	An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children	https://ClinicalTrials.gov/show/NCT00002015	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00001999	A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS	https://ClinicalTrials.gov/show/NCT00001999	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00001061	Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS	https://ClinicalTrials.gov/show/NCT00001061	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00001034	The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV	https://ClinicalTrials.gov/show/NCT00001034	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00000989	The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS	https://ClinicalTrials.gov/show/NCT00000989	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00000894	Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis	https://ClinicalTrials.gov/show/NCT00000894	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	2000-06-30
NCT00000836	A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)	https://ClinicalTrials.gov/show/NCT00000836	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00000799	HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol	https://ClinicalTrials.gov/show/NCT00000799	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00000766	CMV Retinitis Retreatment Trial	https://ClinicalTrials.gov/show/NCT00000766	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	1995-09-30
NCT00000726	Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome	https://ClinicalTrials.gov/show/NCT00000726	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00000698	A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis	https://ClinicalTrials.gov/show/NCT00000698	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00000693	Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS	https://ClinicalTrials.gov/show/NCT00000693	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00000691	A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure	https://ClinicalTrials.gov/show/NCT00000691	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00000688	A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS	https://ClinicalTrials.gov/show/NCT00000688	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	1995-02-28
NCT00000673	A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy	https://ClinicalTrials.gov/show/NCT00000673	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00000668	A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir	https://ClinicalTrials.gov/show/NCT00000668	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00000665	Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component	https://ClinicalTrials.gov/show/NCT00000665	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	1992-04-30
NCT00063765	Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye	https://ClinicalTrials.gov/show/NCT00063765	Completed	National Institutes of Health Clinical Center (CC)	NA
NCT00002330	A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS	https://ClinicalTrials.gov/show/NCT00002330	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00065455	Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT00065455	Completed	National Institutes of Health Clinical Center (CC)	NA
NCT00001062	A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes	https://ClinicalTrials.gov/show/NCT00001062	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00004827	Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT00004827	Completed	FDA Office of Orphan Products Development	NA
NCT00004794	Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis	https://ClinicalTrials.gov/show/NCT00004794	Completed	Office of Rare Diseases (ORD)	NA
NCT00000143	Studies of Ocular Complications of AIDS (SOCA)–Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)	https://ClinicalTrials.gov/show/NCT00000143	Completed	Johns Hopkins Bloomberg School of Public Health	2000-06-30
NCT00000142	Studies of the Ocular Complications of AIDS (SOCA)–HPMPC Peripheral CMV Retinitis Trial (HPCRT)	https://ClinicalTrials.gov/show/NCT00000142	Completed	Johns Hopkins Bloomberg School of Public Health	1996-02-29
NCT00000136	Studies of the Ocular Complications of AIDS (SOCA)–Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)	https://ClinicalTrials.gov/show/NCT00000136	Completed	Johns Hopkins Bloomberg School of Public Health	1991-10-31
NCT00000135	Studies of the Ocular Complications of AIDS (SOCA)–Monoclonal Antibody CMV Retinitis Trial (MACRT)	https://ClinicalTrials.gov/show/NCT00000135	Completed	Johns Hopkins Bloomberg School of Public Health	1996-08-31
NCT00000134	Studies of the Ocular Complications of AIDS (SOCA)–Cytomegalovirus Retinitis Retreatment Trial (CRRT)	https://ClinicalTrials.gov/show/NCT00000134	Completed	Johns Hopkins Bloomberg School of Public Health	1995-03-31
NCT00000118	Ganciclovir Implant Study for Cytomegalovirus Retinitis	https://ClinicalTrials.gov/show/NCT00000118	Completed	National Eye Institute (NEI)	NA
NCT00000116	Randomized Trial for Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT00000116	Completed	National Eye Institute (NEI)	NA
NCT00000114	Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT00000114	Completed	National Eye Institute (NEI)	NA

Observational Studiess

#If less then 500 studies

nct_id	brief_title	link	overall_status	source	primary_completion_date
NCT03322930	Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)	https://ClinicalTrials.gov/show/NCT03322930	Completed	Retina Foundation of the Southwest	2019-03-01
NCT03314207	Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP)	https://ClinicalTrials.gov/show/NCT03314207	Recruiting	Applied Genetic Technologies Corp	2021-12-31
NCT03281005	Development of Visual Function Evaluation Method	https://ClinicalTrials.gov/show/NCT03281005	Completed	Astellas Pharma Inc	2019-11-21
NCT03146078	Rate of Progression in USH2A-related Retinal Degeneration	https://ClinicalTrials.gov/show/NCT03146078	Active, not recruiting	Jaeb Center for Health Research	2023-01-31
NCT02759952	Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy Trial	https://ClinicalTrials.gov/show/NCT02759952	Enrolling by invitation	STZ eyetrial	2025-12-31
NCT02575430	Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT	https://ClinicalTrials.gov/show/NCT02575430	Completed	QLT Inc.	2016-03-31
NCT02303288	Post-Market Study of the Argus® II Retinal Prosthesis System - France	https://ClinicalTrials.gov/show/NCT02303288	Completed	Second Sight Medical Products	2018-03-20
NCT01949623	Biomarkers In Retinitis Pigmentosa (BIRP)	https://ClinicalTrials.gov/show/NCT01949623	Completed	Johns Hopkins University	2017-06-30
NCT01876147	Visual and Functional Assessment in Low Vision Patients	https://ClinicalTrials.gov/show/NCT01876147	Completed	University of Oxford	2016-03-31
NCT01860092	New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System	https://ClinicalTrials.gov/show/NCT01860092	Active, not recruiting	Second Sight Medical Products	2023-08-31
NCT01790958	Microcurrent Stimulation to Treat Macular Degeneration	https://ClinicalTrials.gov/show/NCT01790958	Completed	Retina Institute of Hawaii	2012-12-31
NCT03349242	Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)	https://ClinicalTrials.gov/show/NCT03349242	Recruiting	MeiraGTx UK II Ltd	2022-12-30
NCT01431326	Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care	https://ClinicalTrials.gov/show/NCT01431326	Completed	Duke University	2019-11-30
NCT04312672	Long Term Follow-Up Gene Therapy Study for XLRP RPGR	https://ClinicalTrials.gov/show/NCT04312672	Recruiting	MeiraGTx UK II Ltd	2023-06-30
NCT04281732	Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision	https://ClinicalTrials.gov/show/NCT04281732	Recruiting	Queen’s University, Belfast	2020-09-30
NCT03975543	Retrospective Natural History Study of Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT03975543	Active, not recruiting	SparingVision	2019-07-31
NCT03901391	Prospective Open Clinical and Genetic Study of Patients With Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT03901391	Enrolling by invitation	Sensor Technology for Deafblind	2020-10-01
NCT03753893	Ocular Manifestations in Rheumatic Diseases	https://ClinicalTrials.gov/show/NCT03753893	Active, not recruiting	Lawson Health Research Institute	2020-10-01
NCT03626207	Development of Visual Function Evaluation Method (2)	https://ClinicalTrials.gov/show/NCT03626207	Completed	Astellas Pharma Inc	2019-06-26
NCT01021982	Evaluation of Objective Perimetry Using Pupillometer	https://ClinicalTrials.gov/show/NCT01021982	Completed	Sheba Medical Center	2013-01-31
NCT02014389	Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer	https://ClinicalTrials.gov/show/NCT02014389	Recruiting	Sheba Medical Center	2020-12-31
NCT04127006	Rate of Progression in EYS Related Retinal Degeneration	https://ClinicalTrials.gov/show/NCT04127006	Recruiting	Jaeb Center for Health Research	2024-01-31
NCT01432847	Cell Collection to Study Eye Diseases	https://ClinicalTrials.gov/show/NCT01432847	Recruiting	National Institutes of Health Clinical Center (CC)	NA
NCT00784901	Study of the Correlation Between Macular Thickness Analyzed by Optical Coherence Tomography and the Visual Functions in Retinitis Pigmemtosa	https://ClinicalTrials.gov/show/NCT00784901	Completed	National Taiwan University Hospital	2008-11-30
NCT00559234	Potential Research Participants for Future Studies of Inherited Eye Diseases	https://ClinicalTrials.gov/show/NCT00559234	Completed	National Institutes of Health Clinical Center (CC)	NA
NCT00475254	Stress and Vision Fluctuations in Retinitis Pigmentosa	https://ClinicalTrials.gov/show/NCT00475254	Completed	Johns Hopkins University	2011-04-30
NCT00378742	Repository for Inherited Eye Diseases	https://ClinicalTrials.gov/show/NCT00378742	Active, not recruiting	National Institutes of Health Clinical Center (CC)	NA
NCT00254605	Retinal Imaging in Patients With Inherited Retinal Degenerations	https://ClinicalTrials.gov/show/NCT00254605	Recruiting	University of California, San Francisco	2023-10-31
NCT00231010	Molecular Genetics of Retinal Degenerations	https://ClinicalTrials.gov/show/NCT00231010	Completed	National Institutes of Health Clinical Center (CC)	NA
NCT00106743	Natural History and Genetic Studies of Usher Syndrome	https://ClinicalTrials.gov/show/NCT00106743	Completed	National Institutes of Health Clinical Center (CC)	NA
NCT00091884	Efficacy of Elevated CD4 Counts on CMV Retinitis	https://ClinicalTrials.gov/show/NCT00091884	Completed	National Institutes of Health Clinical Center (CC)	NA
NCT00341172	The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus Retinitis	https://ClinicalTrials.gov/show/NCT00341172	Completed	National Institutes of Health Clinical Center (CC)	NA
NCT00005572	A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection	https://ClinicalTrials.gov/show/NCT00005572	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00000905	A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy	https://ClinicalTrials.gov/show/NCT00000905	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00016471	A Genetic Analysis of Usher Syndrome in Ashkenazi Jews	https://ClinicalTrials.gov/show/NCT00016471	Completed	National Center for Research Resources (NCRR)	NA
NCT00001734	Screening for NEI Clinical Studies	https://ClinicalTrials.gov/show/NCT00001734	Completed	National Institutes of Health Clinical Center (CC)	NA
NCT00001611	Immune Activity Against CVM Retinitis	https://ClinicalTrials.gov/show/NCT00001611	Completed	National Institutes of Health Clinical Center (CC)	NA
NCT00001347	Study of Usher Syndromes, Type 1 and Type 2	https://ClinicalTrials.gov/show/NCT00001347	Completed	National Institutes of Health Clinical Center (CC)	NA
NCT00000168	Longitudinal Study of Ocular Complications of AIDS (LSOCA)	https://ClinicalTrials.gov/show/NCT00000168	Completed	Johns Hopkins Bloomberg School of Public Health	2013-08-31

Registries

#If less then 500 registries

nct_id	brief_title	link	overall_status	source	primary_completion_date
NCT03319524	Clinical and Genetic Testing of Patients With Usher Syndrome	https://ClinicalTrials.gov/show/NCT03319524	Completed	Sensor Technology for Deafblind	2018-04-01
NCT02435940	Inherited Retinal Degenerative Disease Registry	https://ClinicalTrials.gov/show/NCT02435940	Recruiting	Foundation Fighting Blindness	2037-06-30
NCT01793168	Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford	https://ClinicalTrials.gov/show/NCT01793168	Recruiting	Sanford Health	2100-12-31
NCT04128150	High Resolution Retina Imaging	https://ClinicalTrials.gov/show/NCT04128150	Recruiting	Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts	2023-01-30
NCT03990727	Phenotype Correlates Genotype of Inherited Retina Dystrophies, Retinitis Pigmentosa, Con>Rod Dystrophies.	https://ClinicalTrials.gov/show/NCT03990727	Recruiting	MejoraVisionMD	2019-06-13